SYNGR1 and neoplasm: Among the 381 HBV-targeted genes, 35 (AOAH, ANKS1B, CAMTA1, CDH4, CYP2E1, DSCAML1, EXOC4, FCHSD2, FSTL4, HIVEP3, HSPA12A, IGH, IQSEC1, JARID2, KCNQ3, LMF1, MED26, MLPH, MPG, NFAT5, NCOR2, PLD5, PTPRG, PTPRM, TRAPPC9, SLC29A3, SDCCAG8, SMOC1, SYNGR1, TGFBRAP1, WDR66, WNK2, ZHX2, ZMIZ1, ZNF536) were recurrently affected (in 2 or more samples) in tumour tissues and 1 (NRG3) in non-tumour tissues.